Syngene International Share Price

ABOUT Syngene International

• Industry Biotechnology & Drugs
• ISIN INE398R01022
• BSE Code 539268
• NSE Code SYNGENE

Syngene International Limited is an integrated research, development, and manufacturing services company. The Company is engaged in providing contract research and manufacturing services from lead generation to clinical supplies to pharmaceutical and biotechnology companies. Its services include drug discovery and development capabilities in medicinal chemistry, biology, in vivo pharmacology, toxicology, custom synthesis, process research and development (R&D), current good manufacturing practice (cGMP) manufacturing, formulation, and analytical development, along with clinical development services. It offers SynVent, a therapeutic discovery and development platform for executing drug discovery projects. Its business divisions include discovery services, R&D centers, development services, and manufacturing services. It serves the pharmaceuticals, biotechnology, nutrition, animal health, consumer goods, and specialty chemicals. It operates multi-modal biologics manufacturing facility.

MANAGEMENT

• Jonathan Hunt Chief Executive Officer, Managing Director, Executive Director
• Sibaji Biswas Chief Financial Officer, Executive Director
• Deepak Jain Chief Financial Officer
• Andrew Webster Chief Human Resource Officer
• Kenneth Barr Senior Vice President - Discovery Services
• Alex Del Priore Senior Vice President - Manufacturing Services
• Jayashree Aiyar Chief Scientific Officer
• Priyadarshini Mahapatra Head Legal, Company Secretary and Compliance Officer
• Pramuch Goel Head of Corporate Affairs
• Caroline Hempstead Head of Corporate Affairs